chartexchange

RLMD
Relmada Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:59 PM EST
2.86USD-5.150%(-0.15)1,860,822
Pre-marketNov 18, 2026 9:27:30 AM EST
2.88USD-4.319%(-0.13)
After-hoursNov 18, 2026 4:00:30 PM EST
2.855USD0.000%(-0.00)
Loading…
Loading…
304.61M
Healthcare
Biotechnology
HQ
Coral Gables, FL, USA
Previous Close
$3.01
Beta
1.92
52-Week High
$8.00 2026-05-06
52-Week Low
$2.85 2026-11-18
SMA 50
$3.70
SMA 200
$5.36
Avg. Vol 10D
1.51M
Avg. Vol 30D
1.68M
Avg. Vol 90D
1.44M
Relative Vol
1.11
106.69M
82.14M
10,839,074
0.4200%
1,100,000
327,973
Sep 30, 2019 · 1-for-4 (reverse)
RLMD Profile

relmada therapeutics (otcqb: rlmd) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. relmada has a diversified portfolio of four lead products at various stages of development including d-methadone (rel-1017) its n-methyl-d-aspartate (nmda) receptor antagonist for neuropathic pain; topical mepivacaine (rel-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (rel-1028) its oral dosage form of the opioid analgesic buprenorphine; and levocap er (rel-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. relmada's product development efforts are guided by the internationally recognized scientific expertise of our research team. relmada's approach is expected to reduce clinical development risks and

RLMD Performance
PeriodPriceDateChangeBeta
1W4.162026-11-12-31.37%8.316
1M3.162026-10-19-9.65%2.309
3M4.832026-08-19-40.89%2.163
6M7.032026-05-19-59.39%1.554
1Y4.182025-11-19-31.70%1.917
2Y2.982024-11-19-4.20%—
5Y20.392021-11-19-86.00%0.785
RLMD Stock Summary

Relmada Therapeutics, Inc. Common Stock (NASDAQ:RLMD) stock price today is $2.86, and today's volume is 1,860,822. RLMD is down 5.150% today. The 30 day average volume is 1.68M. RLMD market cap is $304.61M with 106.69M shares outstanding.